PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-106.93%
Both yoy net incomes decline, with 1097.HK at -152.64%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.00%
Some D&A expansion while 1097.HK is negative at -32.25%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
100.00%
Deferred tax of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
100.00%
SBC growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
217.04%
Slight usage while 1097.HK is negative at -279.64%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
187.68%
Some yoy usage while 1097.HK is negative at -653.47%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-90.74%
Negative yoy while 1097.HK is 442.53%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
80.89%
Some CFO growth while 1097.HK is negative at -50.04%. John Neff would note a short-term liquidity lead over the competitor.
-75.56%
Negative yoy CapEx while 1097.HK is 2.91%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
528.57%
Acquisition spending well above 1097.HK's 163.30%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-801.72%
Negative yoy purchasing while 1097.HK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
2198.91%
Liquidation growth of 2198.91% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-1078.38%
Both yoy lines negative, with 1097.HK at -80.99%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-138.12%
Both yoy lines negative, with 1097.HK at -9.10%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
We repay more while 1097.HK is negative at -148.28%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-81.13%
Negative yoy issuance while 1097.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.